m ms, narc erry avorn rcad co-director · 1:35 – 1:45 presentation: “the impact on academic...

52

Upload: others

Post on 18-Aug-2021

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

   

Page 2: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

            

FotodWinM

orthefirsturpartnersoimplemenevelopmen

Welookforwnsightsbyj

Michael Fis

timethisys.Wehopentyourideant,orevalua

wardtoyouoininguso

scher, MD,

year,thematheirpreseas.Whetheration,NaRC

urcontribuonsocialme

, MS, NaRC

ajorityofthentationswryouneedCADstands

utions.Aspaedia,andst

CAD Direc

heconferenwillinspireysupportonreadytow

artofourctayingconn

ctor J

WelcomeConferencthankyoupastyear,innovatioorganizatcollaboratopportunmorewidThisyear’successfuUnitedStathattheinconnectioyourownofcarean

nceagendacyoutoconnntraining,pworkwithyo

ommunity,nectedtoou

erry Avorn

tothe4thInceonAcadeuforbeingh,we’veseennsfromouions,formetions,andiitiesforADely.

’sconferenlADprograatesandthnspirationyonsyoumakworkonimndpatiento

consistsofnectwithNprogramplaou.

,wehopeyurnetwork.

n, MD, Na

nternationaemicDetailhere!DurinnamazingrpartneredexcitingdentifiedDtobeadop

cewillhighamsfromaeworld.Wyoureceivekeherewilmprovingthoutcomes.

submissionaRCADtolanning,mat

you’llshare.

aRCAD Co

alling—wengthe

new

ptedeven

hlightroundtheehopeeandlmotivatehequality

nsfromearnhowterials

your

o-Director

Page 3: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

 

Page 4: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

DAY 1: MONDAY, NOVEMBER 14TH, 2016 DetailedAgenda&SessionDescriptions

AllmainsessionswillbeheldintheRotundawiththeexceptionofafternoonbreakoutsasnotedPresentationslideswillbeavailableatonourConferenceHubpageatnarcad.orgaftertheconference

8:30AM Breakfast&Networking

9:00AM OPENINGREMARKS:WelcometoNaRCAD2016MichaelFischer,MD,MS,NaRCADDirector

9:30AM KEYNOTETALK:“TheUSPreventiveServicesTaskForce&ImprovingPreventioninPrimaryCare”AnnKurth,PhD,CNM,MPH,FAANDeanandLindaKochLorimerProfessor,YaleUniversitySchoolofNursing

10:15AM MorningBreak

10:30AM EXPERTPANEL:“EngagingMedicalSpecialistsinAD:FromTopicDevelopmenttoDelivery”Moderator:AmandaKennedy,PharmD,BCPSPanelists:LynetteKosar,BSP,MSc,CaitO’Sullivan,BA,BScPh,PharmD,&SarahBall,PharmDThispanelexploresADexperts’professionalexperienceincollaboratingwithmedicalspecialistswhentakingaclinicaltopicfromevidencebaseto1:1deliveryinthefield.Thesessionwillreviewtheadvantagesandchallengesofconsultingwithspecialists,suchasrecognizingthedifferenceinperspectivesbetweenspecialistandprimarycareclinicians.Panelistswillsharestoriesofsuccess,balancingthatwithstrategiestoaddressbarriers,includingrespondingtospecialists’disagreementswithmessagingandmaterials.Opportunitiesforparticipantstoshareexperienceswillbewoventhroughout,withafinalaudienceQ+Aattheendofthepanel.

12:00PM

Lunch

1:00PM

BREAKOUTSESSIONS:“ADinAction”Choosefrom3TrackSelections:

Breakout1:DeconstructingtheADVisitAmandaKennedy,PharmD,BCPS,&BevinK.ShagouryWhatreallyhappensduringa1:1visitwithaclinician?Howdoacademicdetailerspreparetomakeeveryvisitcount?JointhishighlyinteractivesessionfacilitatedbymembersoftheNaRCAD training teamas theybreakdown thekey elements of a successful educationalvisit through small group exercises and problem‐solving. This sessionwill be especiallybeneficialforattendeespreparingtoworkasclinicaleducators,orforthoseseekingnewinsightsandskillsrefinement.Agreatintroductiontothefundamentalsofavisit,andidealforthoseplanningtocompleteafutureNaRCADADtechniquestraining.

Page 5: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Breakout2:It’sAllintheDetailer:ATeam‐BuildingPerspectiveLorenRegier,BA,BSP,TerrynNaumann,BScPh,PharmD,&JessRogersAn effective clinical education program is only as strong as the teambehind it. Howdoexperts in the fieldstayconnectedamidst thechallengesofdiversegeographies,detailerisolation, and behavioral or clinical topic pushback from clinician audiences? Ideal forconference attendees who are initiating new programming and are interested in thecornerstonesofcreatingandgrowingasuccessfulteam.AlsoimportantforthosewhoareactivelymanagingADorrelatededucationaloutreachprogramsandareseekingstrategiestomaketheirteamsmoreeffective.Breakout3:BuildingStrategicPartnerships:IncreasingAccess&ImpactMindyCraig&MikeFischer,MD,MSADprogramsdonotworkinavacuum–successrequiresidentifyingwaysinwhichADcaninteractandbesynergisticwithotherlocalinitiatives.Makingtheseconnectionsrequirescarefullybuildingcollaborationswithlocalpartners.Thissessionwillfocusonhowtogrowacademicdetailingprogramsbybuildingstrongrelationshipswithvariouscommunitystakeholdersforsustainableimpact.

2:30PM AfternoonBreak:Coffee&NetworkingEnjoyanextendedbreak tosharewhatyou’ve learnedatyourbreakoutsession,relax,andconnectwithNaRCADstaffaboutyourprogramming.

3:00PM SPECIALPRESENTATION:“TobaccoTreatmentforPeoplewithSeriousMentalIllness:ACollaborationwithNaRCAD”MarkViron,MD,KathrynZioto,MD,GailLevine,MDMassachusettsMentalHealthCenterPeoplewithseriousmentalillness(SMI)intheUnitedStatesdie,onaverage,25yearsearlierthanthegeneralpopulation.Muchofthisexcessmortalityisdrivenbysmoking,asnearlyhalfofalldeathsinpeoplewithSMIareduetotobacco‐relatedmedicalconditions.LearnfromtheteamatMassMentalHealthCenterinBostonastheydescribetheircollaborationwithNaRCADtoincreasetobaccocessationstreatmentforpatientswithSMIthroughdirectoutreacheducationwithmentalhealthclinicians.TheMMHCteamwillsharemoreabouttheneedtoaddressthisissue,thedevelopmentoftheirintervention,andtheirmostcurrentdataandoutcomes.

3:45PM “Thebiomedicalinformationexplosion,risingcosts,&clinicianburnout:Howacademicdetailingcanhelp.”Dataontheuseofmedicationsandothermedicalproductsandservicesareaccumulatingexponentially,risingcostsareincreasingtheanxietyofpatientsandpayors,andprimarycarecliniciansareundergrowingpressureoverboth.Whilenopanacea,academicdetailingcandoagreatdealtoaddresseachoftheseevolvingissues.JerryAvorn,MD,Co‐DirectorofNaRCAD

4:30PM Day1ClosingRemarksMichaelFischer,MD,MS,DirectorofNaRCADPleasetakeamomenttofilloutourDay1Evaluationform.

5:00PM‐6:00PM

EveningNetworkingReceptionJoinusjustoutsidetheRotundaforhorsd'oeuvresanddrinks!

Page 6: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

DAY 2: TUESDAY, NOVEMBER 15TH, 2016 DetailedAgenda&SessionDescriptions

AllsessionswillbeheldintheRotundawiththeexceptionofafternoonbreakoutsasnotedPresentationslideswillbeavailableonourConferenceHubpageatnarcad.orgaftertheconference

    

8:30AM Breakfast&Networking

9:00AM ReflectionsonLearning:WelcometoDay2MichaelFischer,MD,MS,DirectorofNaRCAD

9:15AM KEYNOTETALK:“EngagingProfessionalSocietiesinImprovingtheQualityofCare:AViewfromtheAmericanCollegeofPhysicians”StevenWeinberger,MD,MACP,FRCPAssociateExecutiveVicePresident,ExecutiveVicePresidentChiefExecutiveOfficerEmeritusAmericanCollegeofPhysicians

10:00AM MorningBreak

10:15AM THEMEDPLENARY:“AcademicDetailing&theOpioidCrisis”Front‐linecliniciansplayanintegralroleinaddressingthecurrentopioidepidemicintheUnitedStates.Thisspecialplenarywillincludepresentationsoninnovativeinterventionscurrentlybeingimplemented,openingupdiscussiononthedifferentclinicaloutreacheducationstrategiesforimprovingthesafetyofopioiduseandtheeffectivenessofchronicpainmanagement.Moderator:KarenLasser,MD,MPHFeaturingPresentationsfrom:

JamesRick,MD&MichaelAscari,PharmD,MHALongBeach,CaliforniaVeteransHealthAdministration

RobertRhyne,MD,&DanelleCallan,MAUniversityofNewMexicoHealthSciencesCenter

MelissaChristopher,PharmD&MarkBounthavong,MPH,PhDVeteransHealthAdministration’sNationalADService

12:00PM

12:45PM

LunchFIELDPRESENTATIONS:“ImprovingOutcomesAcrossaGlobalHealthcareLandscape”Seefollowingpageformoredetailonthiscollectionofhighlightedinterventions.

Page 7: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

#NaRCAD2016 Field Presentations: “ImprovingOutcomesAcrossaGlobalHealthcareLandscape”

ArapidroundofhighlightsfromrecentfieldinterventionsDay2|12:45–2:30p.m.

12:45–12:50 FieldPresentations:TheImportanceofSharingBestPractices

MikeFischer,MD,MS12:50–1:00 Presentation:“ImplementationofanIntegratedApproachtoSafeOpioid

PrescribingandMonitoring” SameerV.Awsare,MD,FACP

ThePermanenteMedicalGroup,California

1:00–1:05 AudienceQ+A

1:05–1:15 Presentation:“Comparisonoftwomethodsofintroductiontoanacademic

detailingprogram:ADHDtreatmentamongpediatricMedicaidpatients.”  JackiTravers,PharmDPharmacyManagementConsultants,OklahomaCity,Oklahoma

1:15–1:20 AudienceQ+A1:20–1:30 Presentation:“TheImpactofLiveWebinarEducationalSessionsonPharmacists’

Learning:PilotProjectinOptimizingProton‐PumpInhibitorUseinPrimaryCare.”  ShirleyYeung,BSc(Pharm),ACPR,MScPublicHealth

BCProvincialAcademicDetailingService,Vancouver,BC,Canada 

1:30–1:35 AudienceQ+A

1:35–1:45 Presentation:“TheImpactonAcademicDetailingofaDrugTherapyPointof

CareTool/Resource(RxFilesDrugCharts)”BrentJensen,BSPRxFilesAcademicDetailingProgram,Saskatoon,SK,Canada

1:45–1:50 AudienceQ+A

1:50–2:10 Presentation:“ADinNorway:WiserUseofNSAIDs&Antibiotics” HaraldChristianLangaas,MPharm,MPH

DepartmentforClinicalPharmacologyandtheRegionalMedicinesInformationandPharmacovigilanceCenter(RELIS),St.Olav’sHospital,Trondheim,Norway

2:10–2:15 AudienceQ+A

2:15–2:25 ContinuedDialogue:AudienceQ+Aforallpresenters2:25–2:30 FieldPresentationOpportunitiesfor2017

Briefreviewoftheprocessforsubmittingpresentationproposals,withalookaheadto2017.NaRCADencouragesyoutomeet&chatwiththe2016FieldPresentersduringtheupcomingafternooncoffeebreak!

Page 8: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

DAY 2: TUESDAY, NOVEMBER 15TH, 2016 DetailedAgenda&SessionDescriptions,Continued

2:30PM AfternoonBreak:Coffee&NetworkingEnjoyanextendedcoffeebreaktoconnectwithspeakersfromtheFieldPresentationsession,prepare foryourafternoonbreakout session, relax,and connectwithNaRCAD staffaboutyourprogramming.

3:00PM

4:30PM

BREAKOUTSESSIONS:“AdvancedLessonsinAD”Choosefrom3TrackSelections:

Breakout1:CreatingClearMessagingfromComplexClinicalTopicsLynetteKosar,BSP,MSc,BrendaSchuster,BSP,ACPR,PharmD,FCSHPAnacademicdetailingtopiccanbecomplexforavarietyofreasons,includingthequantityandqualityoftheevidence,thenumberoftreatmentchoices,orhealthcaresystemissuesthatcontributetogapsinpractice.Thissessionwillhelpparticipantstounderstandandaddressthechallengeofcreatingclear,evidence‐basedmessaging.Participantswillworkwithacomplextopic,activelystrategizingwaystotranslateclinicalinformationintodynamic,engaging,andeffectivecontent.Breakout2:TopicWorkshop:OpioidSafetyinDiverseSettingsRobertRhyne,MD,DanelleCallan,MA,AlishaHerrick,MPH,CHESJamesRick,MD,PriyankaRanderia,MHA,MPHBuildinguponthefoundationlaidbytheThemedPlenary,“AcademicDetailing&theOpioidCrisis”,thisworkshopfeaturestwoofthismorning’splenaryteamsastheyencourageattendeestoproblem‐solvestrategiestoaddresssystemicchallengestoimproveopioidsafety.Idealforattendeeslookingtoexaminewaystoaddressprogrammatic,geographic,andbehavioralchallengestosimilaropioid‐directedinterventions,andwhowanttotakeawaypracticalstrategiesthatcanbeappliedtoprogramsaddressingbehaviorchangearoundrelatedtopicsinprescribingandchronicdiseasemanagement.Breakout3:PragmaticProgramEvaluationNiteeshChoudhry,MD,PhD&MelissaChristopher,PharmDTheevidencebaseforADiswell‐established,fromJerryAvorn’soriginalrandomizedtrialsthroughrecentsystematicreviewsofthemanyfollow‐onstudies.ButforADprograms,likeotherqualityimprovementinterventions,thereisalsotheneedtoassessongoingimpactwithawell‐designedevaluationprocess.Thissessionwillprovideparticipantswithboththeprinciplesofrigorousevaluationaswellasspecific,appliedcasestudies.AhighlyrelevantsessionforADpractitionersormanagersseekingtomonitorandimprovetheirprograms;payersandpolicymakersoverseeingoutreacheducationinitiatives;andresearchersplanningstudiesofAD.ClosingRemarks,FinalAudienceQ+A,&StayingConnectedwithNaRCADTheNaRCADHomeTeam

5:00PM

TowrapupDay2,membersofNaRCAD’shometeamwillfieldquestions,sharevirtualresources,anddiscussthemomentuminthefieldasweheadinto2017.ConferenceAdjournmentPleasecompleteyourDay2Evaluations.

Page 9: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

arc

&acust

Find

AD‐re Suppohivalconfetomresour

narcwhat you

Fe Tools Webin

elatedpublortmateriaerenceserircequeryfo

cad.orgu need to

eaturins,guides,&nars&preslications&alsonavariescontentormsowe

g/learno make yo

g: tipsheetssentationsfeaturesinrietyofclint,includingcanhelpy

ning-ceour progr

nthenewsnicaltopicsgon‐demanyoufindwh

enter ram stron

ndvideohatyounee

nger.

ed.

Page 10: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Day 1 Keynote Biography: ANN KURTH, PhD, CNM, MPH, FAAN DeanandLindaKochLorimerProfessor

YaleUniversitySchoolofNursing

Ann E. Kurth, PhD, CNM, MPH, FAAN is Dean, and Linda KochLorimerProfessor(inauguralchair)of theYaleUniversitySchoolof Nursing. She previously held the inaugural Paulette GoddardChair in Global Health Nursing at New York University (NYU)College of Nursing and was Associate Dean for Research at theNYUCollegeofGlobalPublicHealth.Sheisamemberofthe2014‐2018USPreventiveServicesTaskForce,whichsetsscreeningandprimarycarepreventionguidelinesfortheU.S.

As an epidemiologist and clinically‐trained nurse‐midwife Dr.KurthfocusesonHIV/sexualandreproductivehealthprevention,screening and care, as well as on global health systemstrengthening,usinginformationandcommunicationtechnologiesamong other approaches for health intervention and workforceeducation implementation. Her work has been funded by theNationalInstitutesofHealth(NIAID,NIDA,NIMH,NICHD),theBill

&MelindaGatesFoundation,UNAIDS,CDC,HRSA,andothers,forstudiesconductedintheUnitedStatesandinternationally.Dr.KurthhasconsultedfortheNIH,GatesFoundation,WHO,USAIDandCDC,amongothers.Dr.Kurthhaspublishedover170peer‐reviewedarticles,bookchapters,andscholarlymonographs,including editing one of the first books published on women and HIV (Until the Cure, YaleUniversityPress1993).Dr.Kurthhas receivedawards forher scienceand leadership includingtheFriendsoftheNationalInstituteofNursingResearchAdaSueHinshawResearchAwardandtheInternationalNurseResearcherHallofFameawardfromSigmaThetaTauInternational.Dr.KurthisvicechairoftheConsortiumofUniversitiesforGlobalHealth(thefirstnon‐physicianinthisrole),andaFellowof theAmericanAcademyofNursingandof theNewYorkAcademyofMedicine.Dr. Kurthwas elected as a Fellow to the Institute ofMedicine/National Academy ofMedicinein2013.Dr. Kurth received her A.B. in development studies and African studies from PrincetonUniversity. She earned anM.P.H. from the Columbia University School of Public Health in theDivisionofPopulationandFamilyHealth,witha focusonmaternalandchildhealth.Dr.KurthcompletedherM.S.N.attheYaleUniversitySchoolofNursing,Maternal‐NewbornDivisionandisacertifiednursemidwife (C.N.M.)andregisterednurse (R.N.).ShewasaNational InstitutesofHealth predoctoral fellow in sexually transmitted diseases and U.S. Public Health Servicematernal and childhealth economic fellowat theUniversityofWashington,where she earnedherPh.D.inepidemiology,withaminorinhealthservices.

Page 11: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Day 2 Keynote Biography: STEVEN E. WEINBERGER, MD, MACP, FRCP

AssociateExecutiveVicePresident,ExecutiveVicePresident,ChiefExecutiveOfficerEmeritus,AmericanCollegeofPhysicians

 

Steven Weinberger, MD, MACP, FRCP, recently retired from hisposition as Executive Vice President and Chief Executive Officer(EVP/CEO) of the American College of Physicians (ACP) and iscurrently serving for one year as Associate Executive VicePresident to help with the transition to a new EVP/CEO. HeassumedthepositionofEVP/CEOin2010,afterhavingservedfor6yearsasACP’sSeniorVicePresident forMedicalEducationandPublishing.Aninternistandpulmonologist,Dr.WeinbergerisalsoAdjunct Professor of Medicine at the University of PennsylvaniaandSeniorLectureronMedicineatHarvardMedicalSchool.DuringhistenureatACP,Dr.WeinbergerinitiatedanddevelopedACP’sHighValueCareInitiative,focusedonreducingoveruseandmisuse of care that adds to healthcare costs without benefiting

patients. He also created ACP’s Center for Patient Partnership in Healthcare (CPPH), whichpromoteshealthcare asapartnershipbetweenpatientsandclinicians. TheCPPHcollaborateswithpatientandfamilyorganizationstofurtheracultureinwhichpatientsnotonlyarepartnersintheirowncare,buttheyalsopartnerwithcliniciansandhealthcarepracticesandsystemstoimprovethewaythatcareisdelivered.PriortojoiningACP,Dr.Weinbergerservedonthefull‐timefacultyatHarvardformorethan25years. He was Executive Vice Chair of the Department of Medicine at Beth Israel DeaconessMedical Center, ExecutiveDirector of the Carl J. Shapiro Institute for Education andResearch,and Professor ofMedicine and Faculty Associate Dean forMedical Education at Harvard. Dr.Weinberger has authored over 140 articles and book chapters aswell as a popular textbook,PrinciplesofPulmonaryMedicine,nowinitssixtheditionandtranslatedintomultiplelanguages.He has served on the Editorial Board of The New England Journal ofMedicine and was theFoundingEditor‐in‐ChiefofthePulmonaryandCriticalCareMedicinecomponentofUpToDate.Dr.WeinbergerreceivedhisM.D.fromHarvardandresidencytrainingininternalmedicineattheUniversityofCalifornia‐SanFrancisco,followedbyfellowshiptraininginpulmonarymedicineatthe National Heart, Lung and Blood Institute. He is the recipient of numerous national andHarvard Medical School teaching awards. Dr. Weinberger has been named a Master of theAmerican College of Physicians and a Fellow of the Royal College of Physicians (London). Inappreciationofhisleadership,ACP’sBoardofRegentsrecentlyestablishedanewannualaward,theStevenE.WeinbergerAwardforPhysicianExecutives/Leaders.

Page 12: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

N

NaRCAAD Sta JeDr.DivgerdetoptincthepatandtraSchHoPhStaautoutme

MiDr.resactextmegaireiFisSciHeBricomand

NiDr.PhythetheandconchrinitrescosandsysDeme

ff erryAvorn. Avorn is Pvision of Phriatrician, atailinganditimal medicclude:thesceidentificatitients;progrd pharmaceaining at Colhool in 197ospital in Boarmacoepidandardsforthor of ovetcomes, andedicineandt

ichaelFis.Fischerisasearcher.Hetiveprimarytensiveexpeedicationuseinsfromimpmbursemenscherearnediencedegreealth.Hecomigham&Womponentsofdteachesco

iteeshCho.ChoudhryiysicianintheHospitalistedevelopmedreducespensequencesroniccondittiationandlsearchprogrst‐effectivendcollaboratstems.HeisliveryScienedicineatBr

n,MD|CoProfessor ofharmacoepidanddrug episrecognizecation use, pcientific,poliionandprevramstoimpeutical cost‐lumbiaUniv74, and comoston. He hdemiologyanDevelopingr 500 paped isoneof tthesocialsc

scher,MDageneralinteisanAssocycarephysicerienceindeeandhaspuprovedprescntpolicy,eledhismedicaeinhealthpmpletedresidomen’sHospftheinternaoursesonres

oudhry,MisaProfessohe Division otProgramatentandevaluending.Heisofusingevidtionsandindlong‐termmramfundednessofmedicteswithawialsothefouces. Dr.ChorighamandW

o‐Directorf Medicinedemiology apidemiologisdinternatioparticularlyicy,andsociventionofaprovetheapeffectivenesversity in 19mpleted a rehas served andisamemTrustworthers in the mthemosthigiences.

D,MS|Direternist,phariateProfesscianandeduesigningandublishednumcribing.Hisectronicpresaldegreefromolicyandmadencytrainipital.Heteacalmedicinersearchmeth

MD,PhD|orofMedicinof PharmacotBrighamanuationofnosparticularldence‐baseddesigningstmedicationadbyCVSCarecaltechnoloiderangeofundingExecuudhrypractWomen’sHo

at Harvardand Pharmast, he piononallyasaley in the eldeialfactorsthdversedrugpropriateness analysis.969, receiveesidency inas presidentberoftheInyClinicalPrmedical literghly‐cited re

ectormacoepidemorofMediciucatoratBridevaluatingmerousstudresearchintscribing,andmtheYaleSanagementfnginprimachesinbothresidencyprhodologyatH

ProgramFneatHarvaroepidemiologndWomen’svelstrategielyinteresteddtherapiesftrategiestoodherence.Hemarktostuogiesandcominsurers,emutiveDirectoticesinpatienospital.

Medical Sccoeconomicneered theeadingexpeerly. His mahatshapephgeffects;meessofprescrDr. Avorn ded hisM.D.internal mt of the IntnstituteofMracticeGuidrature on mesearchersw

miologist,anineatHarvagham&WominterventiondiesdemonstterestsincludmedicationSchoolofMefromtheHarycareintertheoutpatierogramatBrHarvardSch

FacultyrdMedicalScgy and PharmsHospital.HestoimprovdintheclinicforthemanaovercomebaeleadsamuudymedicatimparativeefmployersandoroftheCenntgeneralin

chool and Ccs. A generaconcept ofrtonthistoajor areas ohysicians’dredicationadhribingandddid his undfromHarvaedicine at Bternational SMedicineComelines.Dr.Amedication uworking in t

ndhealthserrdandaclinmen’sHospinstoimprovtratingthepudeprescriptnadherenceedicineandarvardSchoornalmedicinentandinparigham&WhoolofPubli

choolandanmacoeconomisresearchfvehealthcarcalandeconagementofcarrierstotreultidisciplinaionadherenffectivenessdhealthdelnterforHealnternal/hosp

hief of theal internist,f academicopicandonof researchugchoices;herencebydrugtaking;ergraduateardMedicalBeth IsraelSociety formmitteeonAvornistheuse and itstheareaof

rvicesnicallyital.Hehasvepotentialtiondrug.Dr.aMasterofolofPublicneatatientomen’scHealth.

nAssociatemicsandfocusesonrequalitynomiccommoneatmentaryce,theresearchiverylthcarepital

Page 13: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

BeBevmadevclaDEpraexptoicuredu

ArAriTecaloMafrocooheathacom

JuJulAcaBaAssparoutinn

evinKathvinmanageanagement,velopedcomassrooms,anETAILS blogactices andperience inintegratedrricula,Beviucation,focu

rielleMatiellemanagechniques seongwith facaster’s Degrom Tufts Unordinating Balthyagingwatenhancetmmunities.

lieBarbeie assists NademicDetachelor of Ssistant inthrticipates intcomes ofnovationinto

leenShages NaRCAD’sgrant wr

mmunicationndhealthcarg, e‐newsletmagnify th

n buildinglearning pin graduateusingonser

ther,MPHesallofNaReries and thcilitating theee in Publicniversity ScBoston‐baseworkshops,thequalityo

erio|EventNaRCAD eveailing and thScience degheDivisionon the implemedicationsopracticeas

goury|Cos external coriting, andns and educre‐basednontter, and phe impact ostrategic

platforms, ad fromEmervingmargin

H|EducatioRCAD’sevenhe annual Ine developmec Healthwithool of Meed elder serandispassioflifeandim

tsAssistantents, includheAcademiree from BofPharmacoementations. She putssapartofth

ommunicatiommunicatid marketincational resn‐profits,Beartner netwof clinical epartnershiand develoerson Collenalizedyouth

on&Trainints,includingnternationaent of clinicth a concendicine. Shervice prograionateaboutmprovethe

ting the annicDetailingBrandeis Unoepidemioloof researchs her passiheNaRCADt

ions&Educions, bringinng skills tsourcesin cvinmanagework, workeducation pips,improvinoping educge with ah.

ingManagegtheAcadel Academiccalmaterialntration in Hhas severa

ams and teatconnectinghealthstatu

nual InternaTraining Seniversity inogyandPhastudies relions of leateam.

cationDireng non‐profto NaRCADlinical settistheNaRCAking to highprograms. Wngcommunicational anddegree in

ermicDetailinDetailing Cs. Arielle reHealth Commal years ofaching evidegotherswithusoftheirfa

ational Conferies. She re2016.As a

armacoeconolated to therning and

ectorfit programD. Havingngs, urbanADwebsite,hlight bestWithcareerity accessd trainingexpressive

ngTrainingConference,eceived hermunicationexperienceence‐basedhresourcesamiliesand

ference oneceived hera Researchomics, Juliee uses andhealthcare

Page 14: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

2016

MiChDr.ofcomMetheVAcurchaincand

SaAssSamgra25AssPhOutheMeDiralsBo

SaResGeSarChmea jDecoleduAcajoinsigph

6 Conf

ichaelAsciefofPharm.MichaelAsPharmacy ampletedhisedical CenteePacificandA Long Beacrrently purampioned nclude systemdoutcomes

ameerV.AsociateExecmeer V. Awaduatedfromyears. Dr.sociate Exearmacy, AduutsideMediceHospitalEedical Grouprectors sinceoservedasardfrom20

arahBall,searchAssiriatricsMedrah Ball recarleston, Soedicalhomeoint appoinpartmentofllaborate wucational ouademic Detning the Degnificantexparmacyacad

ference

cari,Pharmacyatthescarireceiveand his MHpostgradur.Dr.Ascardservesonh Healthcarrsuing hisnumerous pems redesignresearch.

Awsare,McutiveDirecwsare, MD, pmUniversityAwsare joincutive Direult and FamcalServices.thicsCommp’s Campbee1997 to2Chairofthe006to2014.

PharmDistantProfedicalUniverently joinedouth Carolitransformantment as CfClinicalPhwith the Coutreach forailing Serviepartment operiencewithdemicdetail

e Spea

rmD,MHAVALongBeedhisPharmHA from theateresidencri holds an anumeroushre SystemPBlackbelt cerformance, continuou

MD,FACPctor,ThePepractices IntyofCalifornned the Perctor for ThmilyMedicinHeisalsoin

mittee,andsell facility. 2014, andseeBoard’sGo

essor,DivisiorsityofSoutd the Medicina, with cationandprClinical Assiarmacyandollege of Ppractice bece at the Sof Medicinehtheeducatlersandevid

aker Bio

AeachHealthmDfromthee CaliforniacyinClinicaacademic aphospitalcomPharmacy ancertificationimprovemes quality im

ermanenteMternal Medicnia,Irvineinrmanente Mhe Permanene, Risk AdjnvolvedinrervedasChHe has beeervedas itsvernanceCo

onofGenerthCarolinacal Universiurrent conescriptiondstant ProfesdOutcomeSPharmacy inhavior chanouth Carolie. As foundtion,trainindence‐based

ograph

careSystemUniversityoState UnivealPharmacyppointmentmmitteesincnd Therapeuin LEAN

ent projectsmprovement

MedicalGrocine in Cam1989andh

Medical Grouente Medicausted CodinresidentteaciefofMedicen a membsecretary frommitteean

ralInternal(MUSC)ity of Southcentrationsdrugoverdosssor in theciences,atMn projectsnge. Dr. Ballna Collegeing directorgandfieldmdcontentdev

hies

mofRhodeIslersity, LongyattheLongwith theUncludingCo‐Cutics Commiand has s. His areast, pharmaco

oup(TPMG)mpbell, CA. Dhasbeeninpup in 1993,al Group inng, Revenueching,wastcineatthePer of TPMGrom2000 tondtheViceC

Medicinean

h Carolinaon patientsepreventioCollege of

MUSCandcoinvolvingl directed thof Pharmacr of SCORxmanagemenvelopment.

landSchoolBeach. HegBeachVAniversity ofChairoftheittee. He isuccessfullyof interesteconomics,

Dr. Awsarepracticefor, and is ancharge of

e Cycle andtheChairofPermanenteG Board ofo2006.HeChairofthe

nd

(MUSC) int centeredon.ShehasPharmacy,ontinuestoinnovativehe SCORxEcy prior toE, she hastofclinical

Page 15: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

MaProDr.HeVetOuSciaswodirPutheWaMaDaProDeDacerskiforcartobac20volwoaddadm

MeNaOffDr.oveVetPhPhForconchrtheimSchdismatowe

arkBounogramMan.Bounthavoalth Sciencterans Affautcomes Resiences.Hesta pharmac

orked on irectedthePGblicHealthfe Pharmaceuashington.Hanagersinth

anelleCalojectManaepartmentonelleC.Callrtificationinills inpractirthepastfourdiovasculardisseminatechelor'sdeg05andrecelunteer fororth sharingdition, she iministration

elissaChrationalDirecffice,Pharm._Christopheerseeingtheteran Integarmacy fromarmacyPracrmulary Manductedreseronicdiseasemissiontoprovementhizophrenia,sorders. Moaterials,outctrendpractiellasfullyim

nthavong,nager,Acadonggraduatees. He comirs Loma Lsearch andtartedhiscaoeconomicsdentifyingGY‐1ManagfromEmoryutical OutcoHerecentlyaheAcademic

llan,MAager,UniverofFamilyaanhasbeennacademicdice facilitatiouryears.Herdisease(ABe best practgreeinanthrivedhermaTEDxABQ ag. She has vois one of thnresourcefo

ristopherctorAcademacyBenefitser is the Ne implementgrated Servim DuquesnecticeResideanagementearchinheasemanagemoexpandeffof eviden

, and Posttrost of her pcomemoniticepatternsmplemented

MPH,PhDdemicDetailedfromthempleted a PLinda HealtPharmacoe

areerattheVs clinical spcost‐effectivgedCarePhayUniversity.omes ReseaacceptedapcDetailingSe

rsityofNewndCommunanemployedetailingfromonandacaderprojectexBC’s)andwotices and evropologyandaster’sdegreas the speaolunteerede PCORI amorherdepar

r,PharmDmicDetailinsManagemNational Dirtationeffortice Networke UniversityncyandPosat VA Sanalthoutcomementareas.Inforts foredunce basedraumatic Strprogram efors,provideswithimpleADprogram

DlingServiceCollegeofPPGY‐1 Pharthcare Systeeconomics aVeteransAfpecialist. Duve strategiearmacyResi.Markleftthrch and Polpositionattervice.

wMexico'sHnityMedicieeofUNMfmNaRCADidemicdetailxpertiseisonorkingwithvidence‐basdeconomicseeinHealthker liaisonas a grant rmbassadorsrtmentongr

Dng,U.S.Deptment(PBM)Arector of Vts foracademks since 20y, PittsburghstGraduateYn Diego Heesandpharmnrecentyeaucationaloucare in

ress Disordefforts focuserspecificelementationems.

e,VeteransPharmacyatmacy Practem followedat WesternffairsSanDieuring his tenes and foridency;andheVAinordlicy ProgramtheVAason

HealthScieineforover10yin2013andlingonmultnchronicnoruralprovided informatswhichsheEconomicsencouraginreviewer foratUNMandrantapplicat

t.ofVeteranAcademicDVA Academmicdetailin014. She reh PennsylvaYear2inPhalthcare Symacoeconomars,Dr.ChriutreachbyclPain Manaer aswell aon developlectronicaueffortsforth

sAffairsWesternUntice Residend by a fellUniversityegoHealthcnure at thermulary macompletedadertopursum at the UnneoftheNa

encesCente

years.Sherehasbeenaptiple researcon‐cancerpadersandclintion. She horeceivedfroin2011.Dang the sprear PCORI andd a contracttions.

nsAffairsCeDetailingSermic Detailingngexpansioneceived herania. She coharmacoeconystem.Dr. Cmicanalysisistopherhaslinicalpharmagement, Das other subpment of euditandfeedhenewlyde

niversityofncy at thelowship inof HealthareSysteme VA, Markanagement;aMasterofueaPhDinniversity oftionalData

r,

eceivedherpplyingherchprojectsain(CNCP),nicsystemsolds a duelomUNMinnellewasaad of ideasdHRSA. Int and grant

entralrviceg Services,nacrossallDoctor of

ompleted anomicsandChristopherforseveralsembracedmacists forDepression,bstance useeducationaldbacktoolsevelopedas

Page 16: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

MiDirMintheColproresphyteametoher

AlProHeAliMecomacaacWoaspromama

BrAcaBreSashechodruprehosint

AmDirAm20DeVerboameawpatStaRh

indyCraigrectorofPhndyhasbeeeclinicalsetlorado Heaogram inMsearchtoeaysicianassisam.Hermeedicalrecordfullyundersrtodelivert

ishaHerrogramSpecealthExtenssha works fexicowheremmunitypaademicdetaichronicdiseaorth,Texas.Sa Peace Cooviding theaster traineranagementp

rentJenseademicDetent currenskatchewanseeshundrosenbyfamug comparisesentingclinspital pharmterestinpsy

mandaKerector,Vermmandahasd03. Amandatailing Techrmont, Colleard‐certifiededication saward(K08),atient safety.ate of Vermeumatology

g,PA‐C,MhysicianOutenwiththeAtting. Sheeaalth Scienceay 2000. CrnherMaststantinanuedical careerdsclerktopstandtheuntechnicalass

rick,MPH,cialist,SoutsionRuralOfor the SoutsheprovidertnersandoilerforastatasebilingualShemanageorps voluntenecessary cur in Motivatiprogram.   

en,BSPtailer&Drugtly worksasadetaileedsofSaska

milyphysiciason charts onicaltrialevmacist for Schiatry,geri

ennedy,PmontAcademeliveredAcaa regularlyhniques traiege of Medidpharmacisafety througagraduatec. Her primaont, and locyattheUVM

MStreach,ColoABCDteamarnedherpe Center’soncurrentlyterofSciencumberofser has includpracticemanniquedynamsistancetop

,CHESthwestCentOfficer,Univthwest Centesinstructionothernon‐prtewidepainlhealtheducdtheMigraneer in El Saultural framional Interv

gInformatiwith the

er&druginfatchewanfans.Hehassover the lasvidenceasitaskatoonCiiatrics&reh

PharmD,BmicDetailinademicDetaserves asnings. AsAsicine,Dr. Kestinvestigatgh completiocertificateinary care rescal health pMedicalCen

oradoABCDfor8yearsphysicianassChild Healty, she complcedegreeinttingsforteded a varietynager.Thismicsandflowpracticesata

terforHealtversityofNeter for Healnaldesign, trofitorganizmanagemencatorforthentHealthNealvador. Shemework for iiewing and

ionSpecialiRxFiles A

formationspamilyphysicspentmanyst 20 years.relatestodityHospitalhabmedicine

BCPSngProgramailingsessioa faculty fssociate Proennedy is aor.Shehason of an Ahumanfactearch has blans. She hanter.

andbringswsistantdegrth Associatleted additiPediatrics.enyearsprioyofmedicarangeofexwinatypicameaningfu

thInnovatiewMexicolth Innovatiotrainingandzations.Shentinterventiecountyheaetworkinrure is a traineimproved cothe Stanfor

ist,RxFilesAAcademic Dpecialist.Ascians2‐3timhoursupdatHe is invol

drugtherapyfor over 30e.

m,OfficeofPons tooverfacilitator foofessor of Mresidency aextensivetrAHRQ‐fundedtorsandanebeen fundedas a clinical

withherexpeeattheUnte/Physicianonal courseMs.Craigwortojoiningl office posiperiencepocaloffice,whullevel.

ion

on in Silvertechnicalascurrentlyseon.PreviousalthdepartmralVirginia,ed medicalommunicatiod chronic d

ADProgramDetailing Prsanacademmesperyearting&creatlved in reviydecisionm0 years, he

PrimaryCar700participor NaRCADMedicine, Unand fellowshraininginred career deexecutivefeld by AHRQ, pharmacy

perienceinniversityofn Assistantework andworkedasagtheABCDitions fromositionsherhichallows

r City, Newssistancetoervesasthesly,shewasmentinFortandservedinterpreteron. She is aisease self‐

mrogram inmicdetailer,r,ontopicstingRxFilesiewing andmaking.Asahas a keen

re,UVMpants since Academicniversity ofhip‐trainedsearchandevelopmentllowshipinHRSA, thepractice in

Page 17: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

LynetteKosar,BSP,MScInformationSupportPharmacist,RxFilesADProgramFor the past 5 years, Lynette has been part of the RxFiles Academic DetailingProgram teamas an Information SupportPharmacist andAcademicDetailer. Shehasbeenthe leaddetaileronrecentRxFiles topics,and isacontributor/reviewerfor the RxFiles Drug Comparison Charts (10th edition), Geri‐RxFiles (2nd edition)and the RxFiles – Bringing Evidence to Practice section of the Canadian FamilyPhysicianJournal.Shealsoprovidesclinicalpharmacyservicesataheartfunctionclinic,isaresearchassistantwiththeprovincialdrugutilizationteam,andholdsaClinical Assistant Professor designation with the College of Pharmacy. Prior tojoiningtheRxFiles,Lynetteworkedasaclinicalhospitalpharmacist. HaraldChristianLangaas,MPharm,MPHManagingDirector,RegionalMedicinesInformation&PharmacovigilanceCentre(RELIS),Dept.ofClinicalPharmacology,St.Olav’sHospital,Trondheim,NorwayHaraldhasbeenworkingasmanagingdirectorforoneofthefourregionalRELIS‐centres in Norway for four years. At the department of clinical pharmacology inTrondheim he has teamed up with Dr. Roar Dyrkorn, who has beenworking tointroduceAcademicDetailinginNorwayforseveralyearsaftervisitingBostonandAustralia.TogethertheyhavebeenresponsibleforstartingthefirstAD‐programinNorway. Their team has completed twoAD‐campaigns, the first in 2015 and thesecondin2016.Haraldhasexperienceasahospitalpharmacist,andhasalsobeenapharmacymanagerforthreeprimarycarepharmaciesbeforejoiningRELIS.RELISalsooffersa teratology informationservice for thepublic,andaweb‐basedQ&A‐serviceaboutuseofmedicinesforthepublic.KarenLasser,MD,MPHAssociateProfessorofMedicine&PublicHealth,BostonUniversityDr. Lasser’s research focuses on improving quality of care in primary care forunderserved patient populations and reducing health disparities. Dr Lasser ismulti‐PI of a NIDA‐funded cluster randomized trial to determine whether fourimplementation strategies; nurse care management, use of a patient registry,academic detailing, and electronic tools, will increase primary care provideradherence to chronicopioid therapy guidelines and reduceopioidmisuse amongpatients, relative to electronic tools alone. Dr. Lasser’s work has receivedinternational recognition; she has published over 50 peer‐reviewed papers injournalssuchasJAMA,BritishMedicalJournal,andtheAmericanJournalofPublicHealth.Dr.LasserisapracticingprimarycarephysicianatBostonMedicalCenter,thelargestsafety‐nethospitalinNewEngland.

GailShaiLevine,MDMedicalDirector,BrighamandWomen’sPrimaryCareClinicatMassachusettsMentalHealthCenterGailhasbeeninterestedinprimarycareandhealthcaredisparitiessincemedicalschool.Forthepastfouryearsshe’sfullydevotedherprofessionaltimetomedicalcare for chronically severely mentally ill patients. Together with Dr. Viron andothers she is striving to create a fully integrated model of primary care in anambulatorymentalhealthsetting.

Page 18: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

TeDirBeDr.DruPhcomwoMeHowotheaca

CaCliPhDr.resUnScifrophThint

PrMaPritheAdwitprocarpos20

LoProLorsinmeandpramusertraconPra

errynNaurectorofEvneficiary&. TerrynNaug Intelligarmaceuticampleted ahorkedatSt.Pedicineandospital in ClorkinADine clinical phademicdeta

aitO’SullivinicalPharmarmacyPro. O’Sullivansidentialcarniversity ofienceinPhaomtheUnivearmacist werapeuticsIthedrugapp

riyankaRanagementAiyankagraduen went todministrationththeGraduogram throureer in the Vsitions,she15andcurr

orenRegieogramCoorren has guince the firstember of thd consultatiactical applultifaceted irves as aainings. Lorentributor/reacticesectio

umann,BSvaluation,DrPharmaceuaumann is thgence andal ServiceshospitalphaPaul’sasactheHIVCeninical Drug1993whenharmacist foilingprogra

van,BA,Bmacist,ContogramsBCPhas a clin

re,andcommNew BrunsarmacyfromersityofWaith the B.C.Initiative(Unprovalproce

Randeria,Analyst,VeuatedfromJo the Univen and aMasuateinHealtugh whichVA revenuejoined theentlyfocuse

er,BA,BSrdinator,Rxided the devground‐bree Canadianion to varioication of enterventionfaculty facien is co‐editeviewer fornofCanadia

ScPh,PharugIntelliguticalServicheDirector OptimizaDivision,rmacy residclinicalpharntreofExceResearch asheworkedor the CommminCanada

BScPh,PhtinuingMedProvincialAnical pharmmunitypracswick (HonmDalhousieashington.B. Provincialniversityofessandclini

MHA,MPteransHealJohnsHopkiersity of Wsters in PubthAdministshe won the cycle. AfteNational ADesonproject

SPxFilesADSevelopmenteaking pilotAcademicDusprogramevidence tons that suppilitator fortor ofRxFiler Geri‐RxFilanFamilyPh

armDgence&OpticesDivisionofOptimalation BranBritish Coldencyat St.rmacistinthllence.Shehand Drug UsdatLionsGamunity Drua.

harmDdicalEducatAcademicDeacy backgroctice.Sherecours, MedicUniversity,asedonVanAcademicBritishColucalpractice

PHlthAdminisinsUniversi

WashingtonblicHealth PtrationTrainhe nationaler a varietyD Service atmanageme

erviceof this provproject beg

Detailing Coms and initiao practice aport academNaRCAD’sesDrugComles and thehysicianjour

imizationBn,BCMinistrUse/Academ

nch, Medicumbia MinPaul’sHospheareasofPhasworkedse EvaluatioateHospitalug Utilizatio

tionIslandHetailing(PAound in acuceivedaBaccal AnthropandaDoctoncouverIslaDetailing (Pumbia).Caitguidelinem

stration itywithaB.to receivePolicy. SheningProgramACHE awaof project as a Manageentandfiscal

vincial acadgan in 1997ollaborationatives. Lorenand the ongmic detailingAcademic

mparisonCheRxFiles –rnal.

Branch,MedryofHealthmicDetailincal Beneficnistry of Hpital inVancPalliativeCaatVancouvon. TerryninNorthVan Program

HealthCliniAD)Serviceute generalchelorofArtpology), a BorofPharmaand,sheisanPAD) Servichasaresear

methodology

S.inPublica Mastersstarted hermattheMadard and proand datamement Analyloperations

emic detaili7. Loren isand providn’s interestsgoing develg. AdditionDetailing Tarts10thEdBringing E

dicalhngwith theciary andHealth. Shecouver andre,GeneralverGeneralbegan her

ancouveras– the first

ical

l medicine,tsfromtheBachelor ofacyDegreenacademicce and therchinterest.

Healthandin Health

r VA careerdisonVA,aopelled heranagementystin Aprils.

ing serviceactive as aes trainings cover thelopment ofally, LorenTechniquesditionand aEvidence to

Page 19: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

RoCoProRoMeyeaNaComonNe

JamPriDr.grainFelGoandme

JesAcaJesappknoexppromeguiinttoBrAcaBreSeracadetpramedecNupriacaacathe

obertRhy‐Director,Rofessor,Fambert Rhyne,exico, Reseaarsofexperational InstimmunityOrComplimenwMexico.

mesRick,imaryCare. Rick wasaduatedwithMedicinewllowship waldberg.Heid ChairmanemberatUC

ssRogersademicDetss overseesproach to dowledgetraperience adoviders. Jesethodologyfidance forterventionsenhanceevi

rendaSchademicDetenda Schusrvice in Reademic detatailing serviacticeattheedicine residcisions.Sheutrition,Univimary careademic detaademicdetaeUnitedStat

yne,MDResearchCormilyandCo, MD, is co‐arch Involvinrienceinpriitute of HerientedPrimntaryandAlt

,MDePhysicianeducated ahboththeMasatLACouas in ClinicastheOpiaten of the PhIrvineDepa

stailingServithe Centredetermininganslationanddressing thss’s leadersforthesearchealth ca

andimplemidence‐based

huster,BStailer,RxFileter is an aegina, SK, Cailing technices for theeAcademicdents andwis a ClinicaversityofSapharmacy

ailing trainiailer trainingtes.

reistheVicmmunityMfounder of tng Outpatiemarycare,halth fundedmaryCare,coternativeMe

atLongBeat the UnivM.D.andPh.Dunty(USC)aal PharmacoeSafetyInitiharmacy anartmentofM

iceCo‐Direcfor Effectivg the best edinter‐profe researchship role ach,appraisalare professmentationprdperforman

SP,ACPR,esADServicacademic deCanada, andniques coure last 15 yeFamilyMedworks alongsal Assistantaskatchewanresidents.

ings for Rxg skillswork

ceChairofRMedicineDepthe practiceent SettingshasbeenPId projects,ommunity‐bedicine(CAM

eachVAMedversity of IlD.(PharmacandUniversology at theiative(OSI)d TherapeuMedicine.

ctor,Centree Practice’sevidence infessionalcarand evidenat CEP incllanddissemsionals. Jessrojectsthrounce.

PharmD,ceetailer withd a trainingrse. Brendaars and shedicineUnit.side them tProfessorwnandapreBrenda ha

xFiles on nekshops for a

Researchpartment,Ue‐based reseNetwork (andco‐inveand has cobasedmedicM)useinHi

dicalCentellinois Medcology).HissityofSouth UniversityPointofConutics Comm

eforEffectiv(CEP, Toro

n areas suchredelivery.Jce needs ofludesdevelominationofes also cooughpartner

FCSHP the RxFileg facilitatora has beene combinesSheis involo assist in twith the Colceptor forhas been inew topics aacademicde

UNMearch netwoRIOS Net).estigatorononducted raleducationispaniccomm

er(VALB)ical SchoolPostGraduahCarolina(Mof ChicagontactatVALmittee. He is

vePracticeonto, Canadah as clinicaJesshasovef decision moping an aevidence‐baordinates enetworksw

es Academicfor NaRCA

n providingthis with hlvedinteachtheir daily pllege of Phahospitalphanvolved inand has coetailers inC

ork in NewHe has 25nnumerousesearch innaswellasmunitiesin

where heatetrainingMUSC).Hiswith LeonLongBeachs a faculty

a) rigorousal practice,er12years’makers andappropriatesedclinicaleducationalwithaview

c DetailingAD's 2‐dayg academicher clinicalhingfamilyprescribingarmacy andarmacyandfacilitatingo‐facilitatedCanadaand

Page 20: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

JackiTravers,PharmDClinicalAcademicDetailingPharmacist,PharmacyManagementConsultantsJackijoinedPharmacyManagementConsultants(PMC)in2015astheirfirstandonlyacademicdetailingpharmacist.ShehasbeenactiveinthedevelopmentandimplementationofPMC’sacademicdetailingprogramaspartofitsservicetoOklahomaMedicaid.PriortojoiningPMC,sheservedinthepracticesettingsofindependent,hospital,andclinicalpharmacy.ShereceivedaB.SdegreefromtheUniversityofColorado,andaDoctorofPharmacydegreefromtheUniversityofOklahoma.Herprogrameffortsfocusonbridgingthegapbetweeninformationandapplicationinordertoprovidequalityhealthcareinafiscallyresponsiblemanner.MarkViron,MDDirectorofHomeHealthServices,DepartmentofMentalHealth’sMassachusettsMentalHealthCenter(MMHC)Dr.VironisanadultpsychiatristatMMHCinBostonandanAssistantProfessoratHarvardMedicalSchool. Hespecializesinthetreatmentofpsychoticdisordersandtheintegrationofprimaryandbehavioralhealthcareforpeoplewithseriousmentalillness.HegraduatedfromTulaneUniversitySchoolofMedicineandcompletedhispsychiatryresidencyattheMassachusettsGeneralHospital/McLeanResidencyProgram.HeservesasanattendingatMMHC’spartialhospitalprogram,whereheteachesandtrainsresidentsandmedicalstudents.Heisalsotheprojectdirectorfortwogrant‐fundedinitiativesthataimtoenhanceMMHC’sabilitytoprovideintegratedprimaryandbehavioralhealthcare.ShirleyYeung,BSc(Pharm),ACPR,MScAcademicDetailingPharmacistShirleyYeungisanacademicdetailingpharmacistwiththeBCProvincialAcademicDetailing(PAD)service.ShirleyobtainedherBSc(Pharm)fromtheUniversityofBritishColumbiaandthencompletedahospitalpharmacyresidencywithVancouverCoastalHealth‐ProvidenceHealthcare.SherecentlycompletedherMScinPublicHealthintheHealthEconomicsstreamattheLondonSchoolofHygieneandTropicalMedicine.ShirleyhasbeenwithPADsince2010andcoverstheareasofVancouver,Richmond,BellaCoolaandBellaBella.Shehasprovidedsessionsoneightdifferenttopicstohealthcareprovidersintheregion.SheisalsoapreceptorforthehospitalpharmacyresidentsoftheLowerMainlandPharmacyServices.KathrynZioto,MDPsychiatrist,CodmanSquareCommunityHealthCenterKathrynZiotoisanadultpsychiatristatCodmanSquareCommunityHealthCenterinDorchester,Massachusetts.SherecentlygraduatedfromtheHarvardLongwoodPsychiatryResidencyTrainingprogramwhereshespentherfinalyearworkingwithHealthcarefortheHomeless,providingintegratedpsychiatrytotheirstreetteampatients.SheisnowembeddedwithinprimarycareatCodmanSquareHealthCenteraspartofanewhealthcenterinitiativetointegratethedeliveryofbehavioralandphysicalhealthcaretoCodmanpatients.Whileinresidency,sheworkedwithDr.MarkVironandDr.GailLevineatMassachusettsMentalHealthCenterandwiththeNaRCADteamtoprovideacademicdetailingtopsychiatristsregardingtobaccotreatmentforpeoplewithseriousmentalillness.

Page 21: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

TCo

ismadep

by

Thank orefundingpossibleby

Theyasponsor

You tgforNaRCytheAgenc

2016Confrshipfrom

to Ou

AD&theAcyforHealt

ferencewaourcollea

r SpoADConferethcareRese

assupporteguesatAlo

onsors enceSeriesearchandQ

edosaHealth.

Quality.

Page 22: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Smok

Patients20‐yearayear’sfeaMentalHthisappr

Safepresstudies,AMDA, tidentifyohopesto

AsHIV twill requthepastthe uptadevelopmtheeffort

Searchou

king Cess

withseriouaveragelifeaturedpresHealthCentroachtopat

R

scribingforand the tothe nationaopportunitireducepol

treatmentsuireeducatyearwehaake of HIVment, and ittoeventua

abourblogarc

sation Tre

usmentalieexpectancsentationoter,wearetientsstate

Reducing

rnursing‐hopic remainal associatiiesforADilypharmacy

HIV S

have imprtionofhugeaveworkedV pre‐expoimplementallyreduce

uttheintechivesbyc

greatm

eatment f

illnesssmocyreductionnADtoincexcited to

ewide.

Polypha

omepatienns pressingon of medinterventioyinlong‐te

Screening

roved, the fenumbersdwithmultosure propation. Thesetherateof

Leaerventionsclinicaltopmarketing

for Patien

okeathighenduetosmcreasesmokbecollabo

rmacy in

ntswastheg today. Ovdical directnsandareermcare.

g & PrEP I

focus has sofprimarytiplegroupphylaxis, prsemodel infnewHIVc

arn mosthatarespic,orvisit&educati

nts with S

erratesthamoking‐relakingcessatoratingona

Long-ter

efocusforover the paors in possupporting

Implemen

shifted to pycareprovpsusingADroviding snterventioncasestozer

ore shapingthtourLearnonalmate

Serious M

anthegeneatedillnessetiontreatmaPCORI‐fu

rm Care

oneofJerryast year wet‐acute andganADpro

ntation

preventingvidersacroDtoimprovupport onnswill proo.

hefieldofAningCenteerials.

Mental Illn

eralpopulaes.InadditentatMassundedstudy

yAvorn’soe have wod long‐termograminIn

transmissioss thecounveHIVscren training,vide key le

AD.erforexam

ness

ation,withtiontothissachusettsybringing

riginalADrked withm care, todianathat

ion,whichntry.Overeeningandmaterialsessons for

mplesof

Page 23: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Ourparvia cliniresource

They'reline dechighligh

NaRCADscreeninprescribandmor

Visitou

Contactu

rtners areical educatesharing,

e improvicisions. Ouhtsbestpra

D partnerng, improvbingofopire.

rPartnerN

usifyou’dsup

e organization progrtrainings,

ng healthur partneracticesint

r programved accesioids,incre

naNetworkospecialty

liketobelpportersw

ations or inram suppoconferenc

h outcomer networkthefield.

ms in 201ss to sexueasedrefe

arcad.online,andy,andourg

listedaspworkingtog

                          

ndividualsort, materes,blogfea

es throughconnects

16 have sual healthrralstoch

org/padsearchouglobalalp

artofourgethertoi

swhohavials develoatures,and

h provideexperts,

successfulltesting r

hronicdise

artnersurdirectorhabetical

communitimprovepa

e collaboropment, pdsponsors

r educatioshares im

ly increaseresources,easemana

s

ryofpartnlisting.

tyofclinicatientcare

ratedwithprogramevships.

on, informmportant w

ed rates oencourag

agementsp

nersbyloc

caleducatoe.

NaRCADvaluation,

ming frontwork, and

of cancerged saferpecialists,

cation,

orsand

Page 24: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

 

W

 

Weofferaueducators

role

uniqueands.We'rewi

play, lenetw

ddynamiccthyoueach

dive

ecture, dworking,

coursethathstepoftherselearnin

iscussion expert

1

tprovidesheway,offngplatform

n, small panels,

acriticalfoferingpersoms,featurin

group bmodelin

oundationonalizedinng:breakoutng, & mo

forclinicalnstructiont

t sessionore.

loutreachthrough

ns,

Page 25: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

                       

Page 26: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

C

withqu

Catch u

uestions,

up on y

requests

your re

Cotohaveyonarcad@

eading—

FeoseinGaimpinmpAhfo

ontact uourprogr@partne

—every

Fromintervexpertstoeoffaroundtselectsthebeducationanbox.

Grabacupacademicdmpact,frompopulatedcnterventiomanagemenprogramstADasitconhelpingthefortheirpa

usramfeatuers.org

y last d

viewswithexcitingnewthecountrybestofclinanddeliver

ofcoffeeanetailingismruralarecities.Covens,fromHnt,we’rewohighlightntinuestoimtomakeatients.

ured,&con

detail.

hacademicwinitiativey,DETAILSnicaloutrearsitrightto

ndseehowmakingalaeastodenseringdiverIVPrEPtoworkingwittthemoveminformclinethebestd

ntentsha

detailingestakingShandachoyour

wastingsely‐sediabetesthmentofnicians,decisions

aring.

Page 27: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

“PJe 

TquDjonsaWmdmcodplein

anTinJorelik

ProfessioerryAvor

hen,forreasuarterbacks

Deliveringprobasever,bowstandingank,andPCP

Whatdoesallmostfrequenegradationhmedicationsmonsultationsaily.IntheOathologicallyeftinthehanndividuals.

nddisrespec

hatwouldhnsurancereqohnsonbetteecommendakethehealth

onalism, rn,MD,Na

sonswedonsgotrecasta

rimarymediutthestaturgfor‘providPburnoutan

lthishavetontandvisiblehasdevelopmostoften,bs,andmanyOldenTimesyheterogenndsofthePC

ctfulofthen

helpprimaryquirements,erthanherdationsthatthhcareprofe

AcademaRCADCo‐

n’thavethesasgatekeepe

calcareremreanddailyer’)becamenddropoutb

odowithacewaysthattedisintherbutalsoabootherchoices,whichstillneouscoveraCP,andares

Increrequthouocca‘freeandButs

needsofspe

ycarecliniciorcomputedoctordoes.hemoreenliessionalswe

ic Detail‐director

spacetodiscers,andthen

mainedasinnworkofthedegradedinbecamemor

cademicdetathequarterbroleofclinicouttestordeestheprimasurviveinsagesystem,tstillmadew

easingly,sucuirements,alughtful,evidasionalwildedom’whichhealthcare

sometimestcificpatient

ansmakebeer‐basedalgo.Itcouldalsightenedpolspentsoma

ling, and|DETAILS,20

TherestartingmedicalPrimaryabovethrecognizhealthcallalonggrowingaccompacatapult

cusshere,innasswitchb

natelyvitalaePCP(withtnmanysettirecommon.

ailing?Alot.back‐to‐gatecaldecision‐ring,specialarycareclinomepocketthesedecisioellorpoorly

chchoicesalgorithms,aence‐basedandcrazychhcanonoccbudgets.

therestrictiotsandthenu

etterdecisioorithmsthatopavethewliciesseektoanyyearsle

d the Rep016

ewasabintheearlyschool,thatycarephysicheirlowest‐izedforplayiaresystem(g).InmedicaginterestinanyinginsurtPCPsfrom

nthefollowiboardoperat

andsacredathesecondPings.Morale

Oneoftheekeepermaking–folisticianfacestsofouronsarestillyby

redrivenbyandotherresguidancesthhoicessomeasionleadto

onsaresimpuancedjudgm

onswithoutatsometimeswayforwideoachieve.Anarninghow

pairing of

brief,shiy1970s,whetlastedintocians(PCPs)in‐medicineingacentral(as,ofcoursalcentersth‘healthmainrancedesigntheroleofn

ngyearsinmtors.

aP

r

yformulariestrictions.Sohatareusefuepractitioneopotentialh

ple‐minded,mentofthe

allthelimitasfunctionaseradoptionondclinicianstobe.

f Primary

iningmoenIwasfinisaboutthem)seemedpoistaturetoblroleinthee,theyhadbhroughoutthntenance’annsseemedpnerdstoqua

manysetting

s,priorauthometimesthulantidotesrsoccasionaharmtoboth

financially‐dindividualc

ationsofarbiftheyknowoftheevidenscouldagain

y Care”

omentshingmid‐1980s.isedtorisebecomeentirebeendoinghecountry,nditspoisedtorterbacks.

gs,the

horizationhesearetotheallymake–hpatients

driven,linician.

bitrarywMrs.nce‐basednfeelmore

Page 28: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

 

P

 

Nbyo

MabOnoneqedouItskpOimH“gMdorpsere

PublicHealth

NaRCAD:Theingdonebourselfand

Michelle:AltboutasanoOutreachRepotonlytoprnspecificcoquatetobeiducation,firutreachand

t’sessentialkills,sowherovidersareOne‐on‐onepmportantiti

Howcananogetonboar

Michelle:Leifferentreasrdon’thaverovidersareetgoalsandecommenda

“NEmpow

hDetailingFeaturing

anksfortakbytheNYCDdhowyoug

thoughevideoutreachreppresentativeresentthecaontentareasngeffective!rstandforemdcommunica

ourrepshaventheyengaethenequipproviderengistohavea2

outreachrerd”andthin

et’suseobessons.Providethesamekien’tusinggrtakesmallsationsandre

New Yowering

ProgramagMichelleDr

kingthetimDepartmengotinvolved

MicheDetailithenonYorkCbeeninprovidtailorinFosterclinicaoutrea

ence‐basedrresentative,e(detailer)nampaign,busuchassmo!Althoughmmostwelookation.

veexcellentgeproviderpedtogetthgagementhe2‐waycomm

epresentatinkaboutcar

ityasanexaersmaybefindsoftoolsreatcommunstepstowardeframesthem

rk CityProvide

atNewYorkresser,MPH,

DETAILS

metosharentofHealthdinpublich

lle:ThankyingProgramn‐profitandCityDOHMHnhealthcaredersandconngcomplex

ringthatkinaloutreachachreprese

recommend,it’sreallyabneedstobeauttocultivatokingcessatmostofourrktobringon

sellingandsandgettheheirpatientselpsthemunmunicationw

iveencourareasadialo

ample.Withfrustratedthstotreatobenicationtechdsthegoal.Wminorderto

's Healters to Im

CityDepart,SeniorManSINTERVIEWS

thegreatcandMentahealth,spec

youfortheom.Ihaveoverdgovernmen.Throughouemarketingnsumerscanmessagesus

ndofprovideducation.entativetru

dationsprovibouthowyoanexcellentelong‐termtion,hyperterepshaveanteammem

communicaeirbuy‐in,s“onboard”nderstandhowithpatients

ageprovideogue?

obesity,bothatpatients’esityastheyhniques,likeWeworkonocustom‐tai

th Depamprove

tmentofHeager,PrograSERIES

clinicaloutrlHygiene,Mcificallypub

opportunitytr20yearsofntsetting,wiutmyprofesandprovidebettercommsinghealthl

der‐patientInyourexpulyskilleda

idetheframoudeliver,ocommunicarelationshipension,diabebackground

mberswhoha

tions

”.ows.

ersto

thproviders’comorbidcydoothercoemotivationn“coachingsilortheconv

artmente Outco

ealth&Menamming&St

reacheducaMichelle!Teblichealthd

tospeakabofpublichealiththelast1sionalcareeereducationmunicatewiliteracyprin

tengagemeperience,wandsuccess

meworkforwr"sell"thosatoraswellaps.Justbecaetes,etc.,itddinpublicheaveexperien

sandpatientconditionsaonditions;panalinterviewscripts”,whiversationfor

t: omes”

talHygienetrategy

ationworktellusabitadetailing.

outthePubllthexperien12hereatther,myspecian,emphasizinitheachothenciples.

entisacritiwhatmakesful?

whatyou’llsemessages.asapersuasauseyou’rewdoesn’tneceealthorhealnceandsucc

tsarefrustrarebeingexaatientsmighwing(MI),tochtakethekreachpatien

e(DOHMH)

that’sabout

icHealthnceinbothheNewaltyhasnghowerby

calgoalofan

peakTheiveperson,wellversedessarilylthcessin

ated,foracerbatedhtfeelthathelpthemkeynt.

Page 29: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Ifapatientisonlytold,“Youneedtoloseweight,”whichissuchabroadandoverarchinggoal,they’llbefrustrated,andfrankly,non‐adherent.IknowIwouldbe.Encouragingproviderstohavespecificdialoguesusingacustomizedapproachforeachpatientisimportant.Thiskindofdialoguetakesintoaccountpatients’literacybeyondthewrittenandspokenword—itlooksatscientific,fundamental,healthandculturalliteracy,too.Fosteringthatdialogue,andhavingtherighttoolsandresources,iscritical.Howwouldyoudescribeyourprogram’soverallapproachtoprovidereducation?Michelle:Ourfocusisontheentireintervention,notjustaboutmanagingortreatingadisease,butpreventingitfromeveroccurringinthefirstplaceaswell.We’reempoweringproviderstoworkonpreventivestrategieswiththeirpatients,whichcantranslatetobetterproviderandpatientoutcomes.Onethingthat’suniqueaboutpublichealthdetailingisthatwedetailthewholeteamthroughone‐on‐oneinteractions.Evidenceshowsthesetypesofinteractionswithprovidersandstaffaremoreeffectiveatchangingbehavior;however,sometimesduetothemakeupofthepracticewemustconductgrouppresentations.It’snotideal,butitstillallowsustogetthemessagesandmaterialsoutthere.Thelandscapeofhealthcarehaschangedsomuchandismoreteam‐based;weknowtheprovidercan’tdoeverything,sowelookatthebigpicture:whohelpswithintake,counseling,follow‐up?Weconsiderit“thetotalofficecall.”Wedon’tusetheterm“gatekeeper”—wetrainpeoplethateveryoneinthepracticeistobeapproachedanddetailed,whetherit’sadministrative/frontdeskstaff,billers,nurses,providers—everyoneplaysavitalroleinapatient’shealthcare.Sowhenanoutreachrepresentativegoesintoanoffice,theydetail...everyone?Michelle:Ifthereare15peoplewhoworkinanoffice,we’regoingtodetailall15ofthem.It’salot!Sometimes,thepersonwhoisthechampionofanewbehaviororworkflowisn’tgoingtobetheprovider.Weseethefrontdeskstaffasinstrumental;they’reinteractingwithallofthepatients.Weworkwithourteamstoensureeventhefrontdeskstaffreceivesthematerialsandinformation,ratherthanseeingthemmerelyasa“gatekeeper”togettotheproviders.Soundslikealotoftraininggoesintopreparingforyourcampaigns,andforthinkingabouttheentireprocessofeffectiveoutreach.Tellusmoreaboutyourtrainings,andhowyouprepareoutreachrepresentativesondiseasecontenttraining,aswellascommunicationsskills.Michelle:Onaverage,ourtrainingsareabout5daysinlengthandtakeplacetheweekpriortolaunchinganewcampaign.About40percentofthetrainingisdiseasecontent,soweworkwithourinternalHealthDepartmentexperts,aswellasexternalexperts,wherewelearnaboutpreventionstrategies,treatmentstrategies,epidemiologyandthelandscapearoundthekeyrecommendationschosenbasedontheevidenceofthattopic.Weneedtoknowthe‘why’behindthecampaign.

Page 30: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Ofr“fanfrpWancowD

H

MthgrthmbW

buwreuH

Mevpfo

Oncewehaverametheissufeaturesandndfinally“grompharmaublichealth

Wealsodoanalysisofeaommunicatiwell‐prepareDepartmento

Howelsedo

Michelle:Whefield80%reatopportuhey’vefacedmaterialstolarriers,butWhat’sama

uy‐inthatnewetryandlimelationship.scomeback

Howdoyou

Michelle:Evvaluateeffecroviderpracollow‐upvis

ethatunderue,howtopdbenefits”asgainingacomaceuticalmarinteraction

greatdealoachrep.WelonskillsaredtogooutaofHealthan

esyourtea

emeetthrou%ofthetimeunitytocomonthegroulogisticslikeit’snotuntiljorbarrier

eedstohappmitgroupprOncetheygktoconduct

knowwhen

valuationisactiveness.Fctice.Thisait.

rourbelt,wepromotetheswellasthemmitment”,wrketing.Wes,sowewor

froleplayinlookatbodyeeffective,wanddetail.WdMentalHy

mstrategiz

ughoutthec,4outofthe

metogetheraund.Itcouldeparkingnealwe’reouttyourprogr

penforpeopresentationsgettoknowu1:1visitson

nacampaig

alwaysonthoreverycamallowsustos

eshifttosesmaterials,fie“barriersanwhicharephe’re“selling”rkonthoses

ng,includingylanguage,wwedoknowleWetakethisygiene.

zewhenpro

campaigntoe5daysofthasateamanbeanythingarpractices.herethatweramhasfac

pletocomeis,thishasprusandrecognthefollow‐

gnisworkin

hetopofourmpaignwecseeifthereh

ssionsonhoiguringouttndobjectionhrasesthatcandpromotskills.

gvideotapedwhatedgeassessmseriously—t

omotingnew

talkaboutwheweeksotndstrategizegfromacces.Duringtraieseewhat’sed,andhow

inandtalktroventobeagnizetheval‐upandsubs

ngandbeco

rpriorities,aconductaninhasbeenac

wtothens”cometing

d

ments,quizzthey’rerepr

wcampaign

what’sworktheonedaye.Weaskthesstouptakeining,wetrysreallyhappwhaveyou

MistaaccsyschaanmawasmanWh

Mihavins

othestaff.Aaneffectiveslueoftheprsequentcam

omingsucce

andcanbeanitialandfohangeinpra

zes—wemaresentingthe

ns? 

kingandwhaaweektheyemtoreportofrecommeytoanticipatpening.tackledit?

chelle:Abiartingadetacess.ThelanstemsinNYCangedovertexample,seajorityofourasalmostentmallpracticesissue.

hat’schang

chelle:Nowvebecomepstitutions,soAsImentionstrategywhrogram,theympaigns.

essful?

achallengefllow‐upvisiacticefromt

akesureoureNewYork

atisn’t.Ouryareintheotoutonwhaendationsanteandprepa

igchallenge,ilingprograndscapeofhChasdrasticthepastfeweveralyearsrBrooklynttirelymadeswhereacce

edsincethe

w,manyofthpartoflargerothere’scorpnedbefore,aenenteringy’reengaged

foranyprogritwherewetheinitialto

teamis

staffisinofficeit’saatbarriersndarefor

,whenm,isealthcarecallywyears.Asago,theterritoryofupofesswasn’t

en?

hesesitesrporatealthoughintoanewdinhaving

ramtoassessothe

Page 31: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Asutoac

Tsu

orgrim

Additionally,upportingtoogainingamccessandm

That’ssoheluccess.Wra

rganizationareatestimpamportantto

For

weratewhaoolsandresomorecompleaterials.

lpful—progappingup,w

alpriorities.act.Programlookatthed

rmoreinter

atprovidersources.Weaetepictureo

gramswesuwhatother

.Ourprogramsshouldmdataandpla

rviews&pr

sintendtoaalsocollectaofthecampa

upportareakeyadvice

Michprogrthelaofnonecessellinisweinfordetai

Youcamfocusesomakesuretoanthebestc

racticehigh

doptintermalargeamouaign’ssucces

alwayslookwouldyou

helle:Onekramsaboutaunchofacaotonlytheclssarybackgrngandcommell‐prepared,mationtothilingprogram

canscalethionwherethelookattheirourseofacti

hlights,visi

msofthekeyuntofqualitass,especially

kingforinnofferforne

keypointthaistheimporampaign.Icalinicalcontenroundandemunications,confidentahepracticesm.

supordowere’sthegrerorganizatioionwithinth

ittheDETA

Subscr& be comm

Visit&sig

You’llre‐newsopportu

opportuncolleagues

E‐mail

yrecommenativedatabeywhenrepo

novativewaewanddev

atIalwayssprtanceofaroan’temphasntportion,wevidenceforskillssessioandexcitedtisthecorne

wn,dependinatestneedaon’sagendahecapacityy

ILSBlogat

Join ribe to part ofmunity

tusonlineagnupforou

eceivethesletter,updunitiesandnitytosharswithinou

Questi

usatnarca

dationsandecauseit'sartingonbar

aystomeasuvelopingpro

peakwithinobusttraininsizeenoughwhichprovidthecampaigons.Havingatobringthiserstonetoas

ngonyourneandpotentiaandgoals.Ityouhave.

tnarcad.org

Us. our netf our onof expe

atnarcad.ourmailingl

latestblogdatesontradevents,anreyourwourpartnern

ions?ad@partner

alsocriticalrriers,

ureograms?

nterestedngbeforethevaluedesthegn,buttheateamthatsuccessful

eedandalfort’s

g.

work nline erts

orglist.

gs,ourainingndtherkwithnetwork.

rs.org

Page 32: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Page 33: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Notes Page

Page 34: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Notes Page

Page 35: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Notes Page

Page 36: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Notes Page

Page 37: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Notes Page

Page 38: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Notes Page

Page 39: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Notes Page

Page 40: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Notes Page

Page 41: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Notes Page

Page 42: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Notes Page

Page 43: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Notes Page

Page 44: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Notes Page

Page 45: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Notes Page

Page 46: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Notes Page

Page 47: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Notes Page

Page 48: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Notes Page

Page 49: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Notes Page

Page 50: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Notes Page

Page 51: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Notes Page

Page 52: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent

  

Notes Page